Detailed price information for Toast Inc Cl A (TOST-N) from The Globe and Mail including charting and trades.
Health Catalyst (HCAT) delivered earnings and revenue surprises of -50.00% and +1.98%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Healthcare data analytics company Health Catalyst (NASDAQ:HCAT) beat Wall Street’s revenue expectations in Q3 2026, but revenue fell by 26.3% year on year to $56.28 million. The company expects the full year’s revenue to be around $247.5 million, close to analysts’ consensus estimates. Its non-GAAP loss of $0.03 per share was $0.02 above analysts’ consensus estimates.
Detailed price information for Sweetgreen Inc Cl A (SG-N) from The Globe and Mail including charting and trades.
Let’s dig into the relative performance of Health Catalyst (NASDAQ:HCAT) and its peers as we unravel the now-completed Q2 data analytics earnings season.
Detailed price information for Health Catalyst Inc (HCAT-Q) from The Globe and Mail including charting and trades.
Detailed price information for Warby Parker Inc Cl A (WRBY-N) from The Globe and Mail including charting and trades.
Detailed price information for Health Catalyst Inc (HCAT-Q) from The Globe and Mail including charting and trades.
Health Catalyst is back in focus after analysts revised fair value from about US$2.10 to roughly US$1.83 per share, which points to a more cautious stance on the stock. Recent research has shifted from earlier optimism with price targets in the US$2 to US$3 range to current levels closer to US$1.80, as analysts weigh execution risks around churn, divestitures and the durability of growth in its health technology offerings. In this article, you will see how these changing targets fit into the...
Detailed price information for Marketaxess Holdings (MKTX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Health Catalyst Inc (HCAT-Q) from The Globe and Mail including charting and trades.
Detailed price information for Health Catalyst Inc (HCAT-Q) from The Globe and Mail including charting and trades.
Detailed price information for Health Catalyst Inc (HCAT-Q) from The Globe and Mail including charting and trades.
The data analytics company has cycled through three CEOs in eight months. Health Catalyst is betting its newest chief can navigate an AI pivot and revenue headwinds.
Detailed price information for Health Catalyst Inc (HCAT-Q) from The Globe and Mail including charting and trades.
Kohl brings public-company leadership and a record of successful transformation; Ben Albert to continue as Chief Business OfficerSALT LAKE CITY, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Simeon Kohl has been appointed Chief Executive Officer (CEO) and President and a member of the Company’s Board of Directors,
SALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior...
This is the newest page. Registered accounts read further back.